Home > Cashflow Statement > TRIDENT LIFELINE

TRIDENT LIFELINE
Cashflow Statement

COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022
Profit Before Tax₹8.70 Cr₹6.58 Cr₹2.98 Cr
Adjustment ₹0.12 Cr₹0.08 Cr₹0.33 Cr
Changes In working Capital ₹-4.20 Cr₹-25 Cr₹-3.67 Cr
Cash Flow after changes in Working Capital ₹4.61 Cr₹-18 Cr₹-0.36 Cr
Cash Flow from Operating Activities ₹2.23 Cr₹-19 Cr₹-0.21 Cr
Cash Flow from Investing Activities ₹-20 Cr₹-9.69 Cr₹-0.45 Cr
Cash Flow from Financing Activities ₹11 Cr₹42 Cr₹0.80 Cr
Net Cash Inflow / Outflow ₹-7.13 Cr₹14 Cr₹0.14 Cr
Opening Cash & Cash Equivalents ₹14 Cr₹0.18 Cr₹0.01 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹6.65 Cr₹14 Cr₹0.16 Cr

Compare Cashflow Statement of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹289.8 Cr 4.9% -4.9% 33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹117,415.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -0.9% -10% -11.3% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

4.9%

-4.9%

33.5%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses